Inventor · disambiguated record
Wei Zhao
Also filed as: ZHAO WEI · ZHAO WEI-QIN
27 granted patents·30 pending applications·51 citations·filing 2001–2025
93Inventor score
Files withAMGEN INC10CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD6ACUMEN PHARMACEUTICALS INC4FRONTERA THERAPEUTICS INC3TANG YAJIE3
Top patents by PatentIndex Score
57 records- 0188US12224043B2Methods for determining treatment for cancer patientsMEDIMMUNE LLC·Filed 2023·Granted Feb 11, 2025·1 cites·20 claims
- 0288US6552053B2Controlling attention and memory by altering neuronal carbonic anhydrase activityUS HEALTH·Filed 2001·Granted Apr 22, 2003·24 cites·26 claims
- 0387US11798653B2Methods for determining treatment for cancer patientsMEDIMMUNE LLC·Filed 2019·Granted Oct 24, 2023·5 cites·11 claims
- 0483US11807634B2Cyclopropyl dihydroquinoline sulfonamide compoundsAMGEN INC·Filed 2021·Granted Nov 7, 2023·1 cites·27 claims
- 0579US11332459B2Benzimidazole derivatives and their usesTEIJIN PHARMA LTD·Filed 2018·Granted May 17, 2022·2 cites·16 claims
- 0678US9188595B2Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylationZHAO WEI-QIN·Filed 2010·Granted Nov 17, 2015·5 cites·16 claims
- 0777US9309309B2Anti-ADDL monoclonal antibody and uses thereofMERCK SHARP & DOHME·Filed 2014·Granted Apr 12, 2016·3 cites·10 claims
- 0876US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 0975US11939336B2Aryl triazole cagesUNIV INDIANA RES & TECH CORP·Filed 2019·Granted Mar 26, 2024·1 cites·48 claims
- 1075US7682807B2Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylationBRNI NEUROSCIENCES INST·Filed 2002·Granted Mar 23, 2010·6 cites·62 claims
- 1169US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 1265US9320793B2Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2012·Granted Apr 26, 2016·1 cites·1 claims
- 1364US12246012B2Method for treating nervous system injuries using boldine and derivatives thereofUS GOV VETERANS AFFAIRS·Filed 2023·Granted Mar 11, 2025·0 cites·8 claims
- 1464US9310383B2Antibodies, kit and method for detecting amyloid beta oligomersACUMEN PHARMACEUTICALS INC·Filed 2015·Granted Apr 12, 2016·1 cites·8 claims
- 1561US12275830B2Sustained-release antibacterial film and preparation method thereofUNIV ZHEJIANG·Filed 2022·Granted Apr 15, 2025·0 cites·9 claims
- 1661US11707459B2Method for treating nervous system injuries using boldine and analogs thereofUS GOV VETERANS AFFAIRS·Filed 2021·Granted Jul 25, 2023·0 cites·7 claims
- 1761US2013273545A1Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's DiseaseBRNI NEUROSCIENCES INST·Filed 2013·Application pending·0 cites
- 1861US2024002958A1Instant nucleic acid test method and test kit for pathogenic mutantsSHENZHEN INST OF ADV TECH CAS·Filed 2022·Application pending·0 cites
- 1960US9149064B2Method of producing nanofibrillar cellulose with high absorptivity to fat and cholateZHAO WEI·Filed 2014·Granted Oct 6, 2015·1 cites·8 claims
- 2060US2009029355A1Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's DiseaseZHAO WEI-QIN·Filed 2004·Application pending·0 cites
- 2159US9714254B2Anilino podophyllin derivative having antitumor activity, method for preparation thereof, and use thereofUNIV HUBEI TECHNOLOGY·Filed 2014·Granted Jul 25, 2017·0 cites·9 claims
- 2259US2025163064A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 2359US2025223347A1Antigen binding constructs targeting her2 and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2025·Application pending·0 cites
- 2458US11242354B24-sulfur substituted podophyllotoxin derivative and preparation method therefor and use thereofTANG YAJIE·Filed 2020·Granted Feb 8, 2022·0 cites·14 claims
- 2558US10100149B2Method of preparing well-defined polypeptides via ROPUNIV KING ABDULLAH SCI & TECH·Filed 2015·Granted Oct 16, 2018·0 cites·6 claims
- 2658US2025179077A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 2758US2023242632A1Antigen binding constructs targeting her2 and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 2856US2023295243A1Composition and method for treating eye diseasesFRONTERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2955US12029747B2Use of baicalin in preparation of drug for treating tumor irresponsive to immune checkpoint inhibitors (ICIs)/undergoing hyperprogressionUNIV BEIJING FRIENDSHIP HOSPITAL CAPITAL MEDICAL·Filed 2023·Granted Jul 9, 2024·0 cites·2 claims
- 3055US2023295696A1Method for loading nucleic acid molecule on solid supportMGI TECH CO LTD·Filed 2020·Application pending·0 cites
- 3155US2025034167A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 3255US2024383994A1Anti-cd40 antibody and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 3355US2025122222A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 3454US2025059179A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 3554US2024182592A1Multi-specific antibody targeting bcmaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 3654US2020216449A14-Sulfur Substituted Podophyllotoxin Derivative and Preparation Method Therefor and Use ThereofTANG YAJIE·Filed 2020·Application pending·0 cites
- 3754US2024417412A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 3854US2025059205A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 3953US2024343815A1Pharmaceutical composition of anti-il4r antibody and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 4053US2023321281A1Compositions and methods for the treatment of eye diseasesFRONTERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4153US2023321280A1Compositions and methods for the treatment of ocular diseasesFRONTERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4252US7964359B2Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearanceACUMEN PHARMACEUTICALS INC·Filed 2007·Granted Jun 21, 2011·0 cites·2 claims
- 4350US9828386B2Sulfur-substituted podophyllotoxin derivative, synthesis method thereof, and use thereofUNIV HUBEI TECHNOLOGY·Filed 2014·Granted Nov 28, 2017·0 cites·11 claims
- 4450US2023235057A1Bifunctional protein against pd-1 and tgf-betaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 4550US2014106380A1Methods for identifying inhibitors of abeta42 oligomersMERCK SHARP & DOHME CROP·Filed 2013·Application pending·0 cites
- 4649US2023167073A1Aryl or heteroaryl derivativeTEIJIN PHARMA LTD·Filed 2021·Application pending·0 cites
- 4748US2016305961A1Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylationBLANCHETTE ROCKEFELLER NEUROSCIENCES INST·Filed 2015·Application pending·0 cites
- 4847US8796279B24′-demethylepipodophyllotoxin derivative, preparation method and use thereofUNIV HUBEI TECHNOLOGY·Filed 2013·Granted Aug 5, 2014·0 cites·10 claims
- 4947US2015320860A1Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42ACUMEN PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 5043US2013115227A1Anti-addl monoclonal antibody and uses thereofGASPAR RENEE C·Filed 2011·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →